Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Svend K. Petersen-Mahrt is active.

Publication


Featured researches published by Svend K. Petersen-Mahrt.


Nature | 2002

AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification

Svend K. Petersen-Mahrt; Reuben S. Harris; Michael S. Neuberger

After gene rearrangement, immunoglobulin variable genes are diversified by somatic hypermutation or gene conversion, whereas the constant region is altered by class-switch recombination. All three processes depend on activation-induced cytidine deaminase (AID), a B-cell-specific protein that has been proposed (because of sequence homology) to function by RNA editing. But indications that the three gene diversification processes might be initiated by a common type of DNA lesion, together with the proposal that there is a first phase of hypermutation that targets dC/dG, suggested to us that AID may function directly at dC/dG pairs. Here we show that expression of AID in Escherichia coli gives a mutator phenotype that yields nucleotide transitions at dC/dG in a context-dependent manner. Mutation triggered by AID is enhanced by a deficiency of uracil-DNA glycosylase, which indicates that AID functions by deaminating dC residues in DNA. We propose that diversification of functional immunoglobulin genes is triggered by AID-mediated deamination of dC residues in the immunoglobulin locus with the outcome—that is, hypermutation phases 1 and 2, gene conversion or switch recombination—dependent on the way in which the initiating dU/dG lesion is resolved.


Journal of Immunology | 2009

Progesterone Inhibits Activation-Induced Deaminase by Binding to the Promoter

Siim Pauklin; Svend K. Petersen-Mahrt

Regulation of activation-induced deaminase (AID), an essential factor in Ig diversification, can alter not only somatic hypermutation and class switch recombination (CSR), but may also influence oncogenesis. AID deaminates cytosine to uracil in the Ig locus, thereby initiating Ig diversification. Unregulated AID can induce oncogenic DNA alterations in Ig and non-Ig loci, leading to mutations, recombination, and translocations. In this study, we demonstrate that AID mRNA production in activated mouse splenic B cells can be reduced by treatment with the sex hormone progesterone. This down-regulation is independent of translation or splicing and is predominantly achieved by inhibiting transcription. During cell treatment we could detect progesterone receptor bound to the AID promoter in proximity to NF-κB binding. Importantly, the progesterone-induced repression was also extended to the protein level of AID and its activity on somatic hypermutation and class switch recombination.


Autoimmunity | 2013

Hormones and AID: Balancing immunity and autoimmunity

Elisabetta Incorvaia; Lara Sicouri; Svend K. Petersen-Mahrt; Kerstin-Maike Schmitz

The human immune system is a complex dynamic network of soluble factors and specialized cells that can and need to act in an instance or keep a lifelong protection, with the consequence that health has to be maintained through genetic and environmental stimuli. Autoimmunity is a multifactorial disease, where this combination of genetic predisposition and environmental factors lead to disease etiology. As some autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) or other B cell autoimmunities have a very strong female gender bias, hormones, especially estrogen, have been implicated as environmental factors in driving the disease. One of the key regulators of B cell development is activation-induced deaminase (AID), as its molecular mechanism of cytosine deamination induces immunoglobulin affinity maturation and antibody class switching. In this review we will highlight some of the recent findings of how estrogen directly and indirectly activates AID expression, which in turn can lead to immune hyper-stimulation. Those regulatory pathways can be direct when the estrogen receptor (ER) binds the AID promoter, or indirect via activation of transcription factors that enhance AID expression (e.g., HoxC4). Estrogens influence on AID will also be discussed in terms of microRNA processing for miRNA-155 and miRNA-181b. Important other external stimuli, such as EBV virus, in conjunction with estrogen can add another layer of regulation during autoimmune disease progression. Understanding these pathways will become more important as AID has now been implicated to play an important role in immune tolerance and actual elimination of autoantibodies.


Journal of Biological Chemistry | 2003

In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).

Svend K. Petersen-Mahrt; Michael S. Neuberger


Archive | 2010

Activation induced deaminase (AID)

Svend K. Petersen-Mahrt; Reuben S. Harris; Michael S. Neuberger; Rupert Christopher Landsdowne Beale


Archive | 2010

AID in Immunodeficiency and Cancer

Katharina L. Willmann; Sven Kracker; Maria T. Simon; Don-Marc Franchini; Pauline Gardès; Anne Durandy; Svend K. Petersen-Mahrt


Journal of Immunology | 2015

Pillars Article: AID Mutates E. coli Suggesting a DNA Deamination Mechanism for Antibody Diversification. Nature. 2002. 418: 99–103

Svend K. Petersen-Mahrt; Reuben S. Harris; Michael S. Neuberger


Journal of Cell Biology | 2012

A role for the RNA pol II–associated PAF complex in AID-induced immune diversification

Katharina L. Willmann; Sara Milosevic; Siim Pauklin; Kerstin-Maike Schmitz; Gopinath Rangam; Maria T. Simon; Sarah L. Maslen; Mark Skehel; Isabelle Robert; Vincent Heyer; Ebe Schiavo; Bernardo Reina-San-Martin; Svend K. Petersen-Mahrt


GBM Annual Spring meeting Mosbach 2008 | 2008

Epigenetic Reprogramming of 5-meC via DNA Deamination and DNA Repair

Svend K. Petersen-Mahrt; Wolf Reik; Siim Pauklin; Heather Coker


Cell | 2004

Erratum: DNA Deamination Mediates Innate Immunity to Retroviral Infection (Cell (June 13, 2003) 113 (803-809))

Reuben S. Harris; Kate N. Bishop; Ann M. Sheehy; Heather M. Craig; Svend K. Petersen-Mahrt; Ian N. Watt; Michael S. Neuberger; Michael H. Malim

Collaboration


Dive into the Svend K. Petersen-Mahrt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Reuben S. Harris

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian N. Watt

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sven Kracker

Necker-Enfants Malades Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge